Last reviewed · How we verify
Basal Plus
At a glance
| Generic name | Basal Plus |
|---|---|
| Also known as | Lantus (insulin glargine), Apidra (insulin glulisine) |
| Sponsor | Guillermo Umpierrez, MD |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Effect of the DASH Diet on Treatment Outcomes in Adults Diagnosed With Rheumatoid Arthritis (NA)
- How to Bathe a Person With Dementia? A Bathing Intervention Based on Basale Stimulation® for People With Moderate to Severe Dementia (NA)
- Glycemic Variability Comparing Two vs Five Meals in Type 2 Diabetes (NA)
- FLASH Radiotherapy for Skin Cancer (NA)
- Tritordeum-based Foods for IBS Symptoms (NA)
- Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery (PHASE2)
- Surgical or Medical Treatment (PHASE4)
- Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |